Drug Search Results
More Filters [+]

Ilodecakin

Alternative Names: ilodecakin
Latest Update: 2009-09-25
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: IL10 Analogue

Novel Mechanism: Yes

Modality: Large Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Renovo
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Ilodecakin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Injuries/wounds Unspecified

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2009-017400-91

P2

Completed

Unknown

2012-01-10

Interleukin-10

P2

Completed

Injuries/wounds Unspecified

2006-11-01

Recent News Events

Date

Type

Title